Solutions for COVID-19 Therapeutics, Vaccines
Repligen is ready to partner to help fast-track the development and manufacturing of your COVID-19 therapeutics, vaccines and diagnostics.
Use our COVID-19 Hotline for accelerated product availability or expert support.
Repligen IS A technology leader in therapeutics production
Rapid response with COVID-19 accelerated lead times
Proven technologies with broad customer base from clinical to commercial = reduced risk
Adoption in diverse platforms including mAbs, proteins, viruses, plasmids, AAV, Lentivirus, mRNA
Providing high impact solutions with priority support
Expert-guided priority support for rapid technology implementation
Leading technologies for upstream process intensification, downstream processing, process analytics - scalable from bench to production scale
Closed, single-use bioprocessing — single-use, Gamma-irradiated, fully integrated flow paths
Repligen and Navigo Proteins develop affinity ligand for the purification of COVID-19 vaccines
A successful development of an affinity ligand targeting the spike protein, to be utilized in the purification of COVID-19 vaccines, has entered stage two. The program is focused on both scaling up the manufacturing of this ligand, and on the development and validation of the related affinity chromatography resin.
up to 50% faster lead times for Covid-19 programs
Upstream Solutions
Downstream Solutions
Time-saving, cost-lowering Solutions
Needs and Challenges
- Low shear filtration for pDNA and mRNA purification
- Closed single-use systems, automated and standardized platforms
- Demand for manufacturing can be significant so facility thoughput important
Downstream solutions
Needs and Challenges
- High demand biologic - productivity, efficiency, throughput and process economics need to be considered
- Closed single-use, automated and standardized TFF platforms
- Scalable chromatography and filtration solutions
Upstream solutions
Combines centrifugation and primary depth filtration, scalable from 1 to 2000L
Downstream solutions
Needs and Challenges
- High demand biologic - productivity, efficiency, throughput and process economics need to be considered
- Closed single-use, low shear, automated and standardized TFF platforms
- Scalable chromatography and filtration solutions
Upstream solutions
Combines centrifugation and primary depth filtration, scalable from 1 to 2000L
Downstream solutions
- High demand biologic - productivity, efficiency, throughput and process economics need to be considered
- Closed single-use, low shear, automated and standardized TFF platforms
- Scalable chromatography and filtration solutions
Upstream solutions
Combines centrifugation and primary depth filtration, scalable from 1 to 2000L
Downstream solutions
OPUS® Columns with Purolite Protein A Resin
High capacity rPA affinity resin at a fraction of the cost
Spectrum® Hollow Fiber TFF Filters
Low shear TFF,
1400 configurations
Closed, Gamma-irradiated, no cleaning validation
priority Support available remotely or in person
